Miriam Komaromy, MD, is Professor of Medicine at Boston University.  She leads the Grayken Center for Addiction at Boston Medical Center (BMC), and is board-certified in Internal Medicine and Addiction Medicine.

Komaromy’s current research focuses on how to make addiction treatment more appealing, effective, and equitable for Black patients.  She co-leads a clinical trial funded by NIMH on the impact of Collaborative Care for co-occurring opioid use disorder and mental health disorders in primary care settings. She previously served as the Associate Medical Director of the ECHO Institute in New Mexico, where she pioneered the use of the ECHO model to teach primary care teams to treat addiction. She currently serves as the Vice President of the Board of Directors of the Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA), and is a former member of the Board of Directors of the American Society of Addiction Medicine (ASAM).